The estimated Net Worth of Julia A Haller is at least $740 mil dollars as of 3 June 2022. Julia Haller owns over 2,949 units of Bristol-Myers Squibb Co stock worth over $661,747 and over the last 8 years he sold BMY stock worth over $0. In addition, he makes $78,413 as Independent Director at Bristol-Myers Squibb Co.
Julia has made over 11 trades of the Bristol-Myers Squibb Co stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 2,949 units of BMY stock worth $143,292 on 3 June 2022.
The largest trade he's ever made was exercising 2,949 units of Bristol-Myers Squibb Co stock on 3 June 2022 worth over $143,292. On average, Julia trades about 333 units every 39 days since 2016. As of 3 June 2022 he still owns at least 13,619 units of Bristol-Myers Squibb Co stock.
You can see the complete history of Julia Haller stock trades at the bottom of the page.
Dr. Julia A. Haller serves as Independent Director of the Company. She served Ophthalmologist-in-Chief of Wills Eye Hospital in Philadelphia, PA, where she holds the William Tasman, M.D. Endowed Chair (2007-present) Professor and Chair of the Department of Ophthalmology at Sidney Kimmel Medical College at Thomas Jefferson University and Thomas Jefferson University Hospitals (present) Member of the Johns Hopkins faculty, where she held the Katharine Graham Chair in Ophthalmology (until 2007) Trained at the Wilmer Eye Institute at Johns Hopkins where she served as the first female Chief Resident.
As the Independent Director of Bristol-Myers Squibb Co, the total compensation of Julia Haller at Bristol-Myers Squibb Co is $78,413. There are 19 executives at Bristol-Myers Squibb Co getting paid more, with Giovanni Caforio having the highest compensation of $18,767,300.
Julia Haller is 65, he's been the Independent Director of Bristol-Myers Squibb Co since 2019. There are 2 older and 33 younger executives at Bristol-Myers Squibb Co. The oldest executive at Bristol-Myers Squibb Co. is Vicki Sato, 71, who is the Lead Independent Director.
Julia's mailing address filed with the SEC is C/O OUTLOOK THERAPEUTICS, INC., 485 ROUTE 1 SOUTH, BLDG F, SUITE 320, ISELIN, NJ, 08830.
Over the last 17 years, insiders at Bristol-Myers Squibb Co have traded over $318,151,721 worth of Bristol-Myers Squibb Co stock and bought 211,503 units worth $6,601,565 . The most active insiders traders include Lamberto Andreotti, James M Cornelius, eGiovanni Caforio. On average, Bristol-Myers Squibb Co executives and independent directors trade stock every 8 days with the average trade being worth of $1,682,720. The most recent stock trade was executed by Cari Gallman on 1 August 2024, trading 1,061 units of BMY stock currently worth $51,554.
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol-Myers Squibb Co executives and other stock owners filed with the SEC include: